Khan Alim, Benboubetra Mustapha, Sayyed Pakeeza Z, Ng Keng Wooi, Fox Stephen, Beck Gordon, Benter Ibrahim F, Akhtar Saghir
Centre for Genome-based Therapeutics, The Welsh School of Pharmacy, Cardiff University, UK.
J Drug Target. 2004 Jul;12(6):393-404. doi: 10.1080/10611860400003858.
Small interfering RNA (siRNA), antisense oligonucleotides (ODNs), ribozymes and DNAzymes have emerged as sequence-specific inhibitors of gene expression that may have therapeutic potential in the treatment of a wide range of diseases. Due to their rapid degradation in vivo, the efficacy of naked gene silencing nucleic acids is relatively short lived. The entrapment of these nucleic acids within biodegradable sustained-release delivery systems may improve their stability and reduce the doses required for efficacy. In this study, we have evaluated the potential in vitro and in vivo use of biodegradable poly (D,L-lactide-co-glycolide) copolymer (PLGA) microspheres as sustained delivery devices for ODNs, ribozyme, siRNA and DNA enzymes. In addition, we investigated the release of ODN conjugates bearing 5'-end lipophilic groups. The in vitro sustained release profiles of microsphere-entrapped nucleic acids were dependent on variables such as the type of nucleic acid used, the nature of the lipophilic group, and whether the nucleic acid used was single or double stranded. For in vivo studies, whole body autoradiography was used to monitor the bio-distribution of either free tritium-labelled ODN or that entrapped within PLGA microspheres following subcutaneous administration in Balb-c mice. The majority of the radioactivity associated with free ODN was eliminated within 24 h whereas polymer-released ODN persisted in organs and at the site of administration even after seven days post-administration. Polymer microsphere released ODN exhibited a similar tissue and cellular tropism to the free ODN. Micro-autoradiography analyses of the liver and kidneys showed similar bio-distribution for polymer-released and free ODNs with the majority of radioactivity being concentrated in the proximal convoluted tubules of the kidney and in the Kupffer cells of the liver. These findings suggest that biodegradable PLGA microspheres offer a method for improving the in vivo sustained delivery of gene silencing nucleic acids, and hence are worthy of further investigation as delivery systems for these macromolecules.
小干扰RNA(siRNA)、反义寡核苷酸(ODN)、核酶和脱氧核酶已成为基因表达的序列特异性抑制剂,在多种疾病的治疗中可能具有治疗潜力。由于它们在体内迅速降解,裸基因沉默核酸的疗效相对短暂。将这些核酸包裹在可生物降解的缓释递送系统中可能会提高其稳定性并降低有效剂量。在本研究中,我们评估了可生物降解的聚(D,L-丙交酯-共-乙交酯)共聚物(PLGA)微球作为ODN、核酶、siRNA和脱氧核酶的持续递送装置在体外和体内的应用潜力。此外,我们研究了带有5'-末端亲脂性基团的ODN缀合物的释放情况。微球包裹的核酸的体外持续释放曲线取决于所用核酸的类型、亲脂性基团的性质以及所用核酸是单链还是双链等变量。对于体内研究,使用全身放射自显影术监测游离的氚标记ODN或皮下注射到Balb-c小鼠体内后包裹在PLGA微球中的ODN的生物分布。与游离ODN相关联的大部分放射性在24小时内被清除,而聚合物释放的ODN即使在给药后七天仍在器官和给药部位持续存在。聚合物微球释放的ODN表现出与游离ODN相似的组织和细胞嗜性。肝脏和肾脏的微放射自显影分析表明,聚合物释放的ODN和游离ODN具有相似的生物分布,大部分放射性集中在肾脏的近端曲管和肝脏的库普弗细胞中。这些发现表明,可生物降解的PLGA微球提供了一种改善基因沉默核酸体内持续递送的方法,因此作为这些大分子的递送系统值得进一步研究。